Silverberg Bernstein Capital Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
99,476
+3,939
| +4% | +$56.8K | 0.98% | 30 |
|
|
2025
Q1 | $659K | Buy |
95,537
+15,000
| +19% | +$104K | 0.61% | 38 |
|
|
2024
Q4 | $427K | Sell |
80,537
-2,720
| -3% | -$14.4K | 0.38% | 39 |
|
|
2024
Q3 | $304K | Buy |
83,257
+1,100
| +1% | +$4.02K | 0.28% | 41 |
|
|
2024
Q2 | $224K | Hold |
82,157
| – | – | 0.22% | 43 |
|
|
2024
Q1 | $286K | Sell |
82,157
-600
| -0.7% | -$2.09K | 0.28% | 41 |
|
|
2023
Q4 | $118K | Buy |
+82,757
| New | +$118K | 0.11% | 49 |
|